The ImmunoHUB project is delighted to congratulate the ISSD team for being awarded funding in the latest FCT PEX 2024 call! This prestigious grant of 50K EUR will support groundbreaking research on the role of AHR in melanoma, led by the Pedro Moura Alves Lab at i3S.This project is headed by Pakavarin Louphrasitthiphol, our esteemed collaborator from the Ludwig Institute for Cancer Research, Oxford University. Their work will provide valuable insights into AHR signaling in melanoma progression and immune regulation.
